Moleculin Biotech, Inc. Nontrade Receivables, Current
Moleculin Biotech, Inc. (MBRX) had Nontrade Receivables, Current of $4.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:NontradeReceivablesCurrent · last filed 2026-08-13
- 2026-06-30: Nontrade Receivables, Current $4.00K.
- 2026-03-31: Nontrade Receivables, Current $9.00K.
- 2025-12-31: Nontrade Receivables, Current $7.00K.
- 2025-09-30: Nontrade Receivables, Current $2.00K.
| Period end | Nontrade Receivables, Current | Nontrade Receivables, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $7.00K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $2.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $2.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $20.00K 10-K · filed 2026-03-18 | $16.00K 10-K · filed 2025-03-21 |
| 2024-06-30 | $5.00K 10-Q · filed 2024-08-13 | |
| 2023-12-31 | $95.00K 10-K · filed 2025-03-21 | |
| 2023-06-30 | $7.00K 10-Q · filed 2023-08-10 | |
| 2022-12-31 | $2.00K 10-K · filed 2024-03-22 | |
| 2022-09-30 | $6.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $5.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $5.00K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $23.00K 10-K · filed 2023-03-22 | |
| 2020-12-31 | $1.00K 10-K · filed 2022-03-24 | |
| 2020-09-30 | $1.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $3.00K 10-Q · filed 2020-08-12 | |
| 2019-12-31 | $1.00K 10-K · filed 2021-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |